Filing summary: IKONICS Corporation, Form 10-Q
Important identification discrepancy: The request identifies TERAWULF INC., but the supplied filing is for IKONICS Corporation, a Minnesota company. The filing covers the quarter ended June 30, 2015, and was signed August 13, 2015. The financial statements are unaudited.
Business context and reporting period
IKONICS sells imaging, screen-printing, digital-texturing and advanced-material products and services through five reported segments: Domestic, Export, IKONICS Imaging, DTX and AMS. Its AMS business serves aerospace and other advanced-material applications. Results below compare the three and six months ended June 30, 2015 with the same periods in 2014.
Key financial results
| Metric | Q2 2015 | Q2 2014 | First half 2015 | First half 2014 |
|---|---|---|---|---|
| Net sales | $4.654 million | $4.925 million | $8.251 million | $9.389 million |
| Gross profit / margin | $1.640 million / 35.2% | $1.711 million / 34.7% | $2.740 million / 33.2% | $3.470 million / 37.0% |
| Operating income (loss) | $195,000 | $293,000 | ($276,000) | $608,000 |
| Net income (loss) | $28,000 | $198,000 | ($201,000) | $403,000 |
| Diluted EPS | $0.01 | $0.10 | ($0.10) | $0.20 |
At June 30, 2015, cash and cash equivalents were $2.369 million and short-term investments were $1.205 million. Current assets were $8.663 million against current liabilities of $952,000. Total liabilities were $1.497 million; the company reported no borrowings outstanding. The unused line of credit was $1.25 million at quarter-end, subsequently increased to $2.05 million in July.
For the first half, operating activities provided $469,000, compared with $364,000 in 2014. Investing activities used $37,000, versus $984,000 in 2014; capital spending was $568,000. Cash increased by $433,000 to $2.369 million.
Material changes versus prior comparable periods
- Second-quarter sales fell 5.5%; first-half sales fell 12.1%. Export sales weakened amid a softer European economy and a stronger U.S. dollar. First-half IKONICS Imaging sales were also lower, partly because 2014 included a one-time initial stocking order from a new distributor.
- Q2 gross margin percentage improved slightly on sales mix, but gross-profit dollars declined with lower sales. First-half gross margin fell to 33.2% from 37.0%, reflecting the prior-year stocking order’s higher-margin product mix, lower European sales and reduced Domestic volume.
- The company moved from first-half 2014 net income of $403,000 to a first-half 2015 net loss of $201,000. SG&A and R&D expenses increased, including consulting and training costs related to ERP planning and $46,000 of abandoned patent-application costs.
- Q2 AMS sales rose 67% year over year, while first-half AMS sales increased $64,000. However, AMS generated an operating loss in both periods shown; management cited higher labor costs.
Outlook, commitments and risks
- Management expected 2015 capital expenditures of approximately $950,000, excluding the planned building expansion. It committed to a $3.5 million, 27,300-square-foot AMS expansion, expected to be completed in Q2 2016. Management anticipated higher AMS production costs and lower aggregate gross profit in the short term from the expansion, beginning in the second half of 2016.
- The company committed $140,000 toward a new ERP system; the total project was estimated at approximately $400,000, with completion expected by Q2 2016. Expansion and other capital spending were expected to be funded with cash, operating cash flow and potentially the credit line.
- Management said current resources and financing capacity should be sufficient for anticipated operations. It cited continued U.S. dollar strength as a near-term challenge to international growth and described AMS and DTX development opportunities, including aerospace feasibility projects, as ongoing rather than assured business.
- There were no reported legal proceedings or off-balance-sheet arrangements. Management stated disclosure controls were effective and reported no material change in internal control over financial reporting. The filing cautions that interim results are not necessarily indicative of full-year results.
Most important facts for investors to verify
- Confirm the issuer: the supplied filing is IKONICS Corporation, not TERAWULF INC.
- Assess whether the sales decline and first-half loss persist, particularly in Export and IKONICS Imaging, and whether gross margins recover.
- Track the cost, timing and funding of the $3.5 million AMS expansion and approximately $400,000 ERP project, including any credit-line use.
- Monitor whether AMS feasibility work and DTX initiatives convert into recurring revenue, and whether added capacity offsets near-term cost pressure.
- Review the unusually high Q2 effective tax rate of 85.9%; management attributed it to low earnings and the relative impact of nondeductible items.